Filip Borgions
Technik-/Wissenschafts-/F&E-Leiter bei ARGENX SE
Aktive Positionen von Filip Borgions
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARGENX SE | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | - |
Karriereverlauf von Filip Borgions
Ehemalige bekannte Positionen von Filip Borgions
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Corporate Officer/Principal | - | - |
Ausbildung von Filip Borgions
Katholieke Universiteit Leuven | Doctorate Degree |
Statistik
International
Niederlande | 2 |
Belgien | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ARGENX SE | Health Technology |
Private Unternehmen | 1 |
---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
- Börse
- Insiders
- Filip Borgions
- Erfahrung